Literature DB >> 12552969

Increasing incidence of cholangiocarcinoma in Crete 1992-2000.

Ioannis A Mouzas1, Philippos Dimoulios, Ioannis G Vlachonikolis, Panagiotis Skordilis, Odysseus Zoras, Elias Kouroumalis.   

Abstract

BACKGROUND: There have been recent reports of an increased incidence of cholangiocarcinoma. PATIENTS AND METHODS: Patients with cholangiocarcinoma, resident on the island of Crete, diagnosed between 1992 and 2000, were studied. Case ascertainment was enhanced by collaboration of the pathology departments and all gastroenterologists of Crete in providing relevant data. A specially designed patient protocol was used. Crude incidence rates are presented.
RESULTS: During the 9-year period 7 patients were diagnosed with cholangiocarcinoma of the intrahepatic ducts, 17 with Klatskin and 16 patients with extrahepatic ducts carcinoma. A steady incidence increase of cholangiocarcinoma, irrespective of location, was shown. The estimated incidence rate per three-year period progressively increased from 0.998 to 2.329 and 3.327 per 100,000 for the periods 92-94, 95-97 and 98-2000, respectively. Median survival time was 8.5 months. No significant difference was seen between survival according to the location of cholangiocarcinoma.
CONCLUSION: A steady incidence increase of cholangiocarcinoma cases in Crete during the time-period 1992-2000 was shown.

Entities:  

Mesh:

Year:  2002        PMID: 12552969

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

Review 1.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Authors:  William C Palmer; Tushar Patel
Journal:  J Hepatol       Date:  2012-03-13       Impact factor: 25.083

Review 2.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

3.  A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma.

Authors:  Huabang Zhou; Xiaolan Jiang; Qiaomei Li; Jingyi Hu; Zhengrong Zhong; Hao Wang; Hui Wang; Bing Yang; Heping Hu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 4.  Epidemiology and risk factors: intrahepatic cholangiocarcinoma.

Authors:  Amar Gupta; Elijah Dixon
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

5.  The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma.

Authors:  Yeongjoo Lee; Ie Ryung Yoo; Sun Ha Boo; Hyoungwoo Kim; Hye Lim Park; Joo Hyun O
Journal:  Nucl Med Mol Imaging       Date:  2016-08-06

6.  A nationwide population-based study shows increasing incidence of cholangiocarcinoma.

Authors:  Teng-Yu Lee; Jaw-Town Lin; Ken N Kuo; Ming-Shiang Wu; Hsiu J Ho; Tzu-Ting Chen; Chun-Ying Wu
Journal:  Hepatol Int       Date:  2012-05-16       Impact factor: 6.047

7.  Cholangiocarcinoma: expanding the spectrum of risk factors.

Authors:  Diaa H Elfaki; Andrea A Gossard; Keith D Lindor
Journal:  J Gastrointest Cancer       Date:  2009-01-14

8.  Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma.

Authors:  Andreas Weber; Claus von Weyhern; Falko Fend; Jochen Schneider; Bruno Neu; Alexander Meining; Hans Weidenbach; Roland M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

9.  Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.

Authors:  Yijun Xu; Mingchen Zhu; Shuhong Zhang; Hui Liu; Tao Li; Chengyong Qin
Journal:  Pathol Oncol Res       Date:  2009-09-09       Impact factor: 3.201

Review 10.  Hepatitis B virus infection and intrahepatic cholangiocarcinoma.

Authors:  Hua-Bang Zhou; Jing-Yi Hu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.